Published on 19 Jun 2024 on Simply Wall St. · via Yahoo Finance
electroCore, Inc. (NASDAQ:ECOR) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The US$40m market-cap company’s loss lessened since it announced a US$19m loss in the full financial year, compared to the latest trailing-twelve-month loss of US$16m, as it approaches breakeven. The most pressing concern for investors is electroCore's path to profitability – when will it breakeven? We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.
See our latest analysis for electroCore